/Boston%20Scientific%20Corp_%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
Marlborough, Massachusetts-based Boston Scientific Corporation (BSX) is a developer, manufacturer, and marketer of medical devices for use in various interventional medical specialties worldwide. With a market cap of $123.8 billion, the company operates through MedSurg and Cardiovascular segments. It is expected to release its Q3 earnings before the market opens on Wednesday, Oct. 23.
Ahead of the event, analysts expect Boston Scientific to report a profit of $0.58 per share, up 16% from $0.50 per share reported in the year-ago quarter. Moreover, the company has surpassed Wall Street’s EPS projections in each of the past four quarters. Its adjusted EPS for the last reported quarter grew 17% year over year to $0.62, exceeding the consensus estimates by 6.9%.